Hem › Bukspottkörtelcancer › Illinois › Chicago
Kliniska studier för Bukspottkörtelcancer i Chicago, IL
20 studier för Bukspottkörtelcancer söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekryterarFas 1/2
- Research Site, Chicago
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekryterarFas 3
- City of Hope, Chicago
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
RekryterarFas 1
- Northwestern University, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekryterarFas 1
- University of Chicago Hospital, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekryterarFas 2
- University of Illinois Cancer Center, Chicago
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RekryterarFas 3
- University of Chicago Medical Center, Chicago
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekryterarFas 3
- Investigative Site US079, Chicago
CREO - Microwave Ablation Feasibility Study
Rekryterar
- Rush University Medical Center, Chicago
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekryterarObservationsstudie
- Northwestern University, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
RekryterarFas 1/2
- Northwestern University, Chicago
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekryterarFas 3
- Northwestern University, Chicago
- University of Illinois, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Pancreatic Cancer Early Detection Consortium
RekryterarObservationsstudieFriska volontärer välkomna
- University of Chicago Medicine, Chicago
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
RekryterarFas 2
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekryterarFas 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
Lidocaine Infusion in Pancreatic Cancer
RekryterarTidig fas 1
- University of Illnois at Chicago, Chicago
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
RekryterarFas 3
- Northwestern University, Chicago
- University of Illinois, Chicago
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekryterarFas 2
- Ohio State University-Telemedicine, Chicago
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RekryterarObservationsstudie
- Advocate Illinois Masonic Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
RekryterarFas 2
- Northwestern University, Chicago
Bukspottkörtelcancer-studier i andra städer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer59 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Lungcancer41 studier
- Övervikt41 studier
- Äggstockscancer36 studier
- Kolorektal cancer34 studier
- Stroke34 studier
- Hjärtsvikt31 studier
- Övervikt29 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.